Brind.

MoonLake Immunotherapeutics announced financial results from Zug on August 5, 2025, and plans BLA submissions in the US.

1 report, 1 independent Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

MoonLake Immunotherapeutics announced financial results from Zug on August 5, 2025, and plans BLA submissions in the US.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireMoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoin